ROG CH0012032048

Report

Delayed Swiss Exchange - 07/23 11:30:30 am
347.3	CHF		+1.24%

07/23	MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : KGaA Appoints China, International Markets' Health Head	MT
07/23	ROCHE HOLDINGS AG : Credit Suisse reiterates its Neutral rating	MD
07/23	ROCHE : Wolfe Research Lifts Price Target on Roche Holding, Maintains Outperform Recommendation	MT

News

Press Releases

Official Publications

Sector news

MarketScreener Strategies

Communiqués de presse de la société ROCHE HOLDING AG

07/22	ROCHE : Half-year 2021 Investor Update	PU
07/22	ROCHE : Half Year Report 2021	PU
07/22	ROCHE : reports good half-year results - Investor Update	PU
07/22	ROCHE : Half Year 2021 Presentation without appendix	PU
07/22	ROCHE : Half Year 2021 Presentation with appendix	PU
07/22	ROCHE : reports good half-year results	AQ
07/21	ROCHE : FDA Grants Breakthrough Therapy Designation for Venclexta in Combination..	BU
07/20	CHUGAI PHARMACEUTICAL : Antibody Cocktail, RONAPREVE for Intravenous Infusion Se..	AQ
07/20	ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..	AQ
07/20	ROCHE : Japan becomes first country to approve Ronapreve (casirivimab and imdevi..	AQ
07/19	ROCHE : New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Pro..	BU
07/19	ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..	AQ
07/16	REMINDER : Invitation to Roche's Half Year Results 2021 Presentation	PU
07/15	CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishid..	AQ
07/12	CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for ..	AQ
07/09	CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination	AQ
07/09	ROCHE : WHO guidelines now include Roche's diagnostic tests in expanded effort t..	AQ
07/08	CHUGAI PHARMACEUTICAL : Files for Additional Indication of Tecentriq for the Adj..	AQ
07/02	ROCHE : Media resources for Roche's 125 Years Anniversary	AQ
07/02	ROCHE : to present new data at the ISTH 2021 Congress highlighting long-standing..	AQ
06/30	ROCHE : Atea's AT-527, an oral antiviral drug candidate reduces viral replicatio..	PU
06/30	SUPPORTING CANADA'S BACK TO NORMAL : Roche Diagnostics Canada introduces the new..	AQ
06/29	CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission ..	AQ
06/28	ROCHE : ENSPRYNG approved by European Commission as first and only at-home subcu..	AQ
06/25	CHUGAI PHARMACEUTICAL : Genentech Announces FDA Emergency Use Authorization for ..	AQ
06/25	ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..	AQ
06/25	ROCHE : Invitation to Roche's Half Year Results 2021 Presentation	PU
06/25	ROCHE : Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the ..	AQ
06/24	GENENTECH : 's Actemra Receives FDA Emergency Use Authorization for the Treatmen..	BU
06/24	PTC THERAPEUTICS : Evrysdi Approved in Japan for the Treatment of Spinal Muscula..	AQ
06/24	ROCHE : Title test release to ensure the format looks goood	PU
06/24	ROCHE : FDA accepts application for Roche's Port Delivery System with ranibizuma..	AQ
06/24	ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..	BU
06/22	Insulin pump Accessories Market Development, Outline, Competitive perspective..	AQ
06/17	ROCHE : Check You Employment Agreement's Restrictive Covenant	AQ
06/16	ROCHE : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milesto..	AQ
06/15	ROCHE : data at EAN 2021 showcase significant impact of therapies across diverse..	AQ
06/14	CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Faricimab, the F..	AQ
06/14	PTC THERAPEUTICS : Pre-symptomatic Infants with Spinal Muscular Atrophy Achieved..	AQ
06/14	ROCHE : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto co..	AQ
06/11	GENENTECH : Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combinat..	BU
06/11	ROCHE : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto co..	AQ
06/11	ROCHE : New Roche data for Evrysdi show improved motor function in pre-symptomat..	AQ
06/11	ROCHE : New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function ..	BU
06/09	ROCHE : Accu-Chek® Inform II Hospital Blood Glucose System now approved by Healt..	AQ
06/08	CHOROIDEREMIA PIPELINE : Emerging Therapies and Key pharma players involved by D..	AQ
06/08	ROCHE : obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for ..	AQ
06/07	REMINDER : Invitation to Roche's virtual event on key Evrysdi data presented at ..	PU
06/07	ROCHE : Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin's..	AQ
06/07	ROCHE : Dosage Regimens Affirmed In Canada Again	AQ
06/04	GENENTECH : Presents Latest Advances With Immunotherapies in Non-Hodgkin's Lymph..	BU
06/04	ROCHE : presents latest advances with immunotherapies in non-Hodgkin lymphoma	AQ
06/03	ROCHE : Cancer Inclusion Into NHIs Would Reduce Economic Burden - Bagudu	AQ
06/03	MEDULLOBLASTOMA PIPELINE : Emerging Therapies and Key pharma players involved by..	AQ
05/31	REMINDER : Invitation to Roche's virtual event on key oncology data presented at..	PU
05/26	ROCHE : Invitation to Roche's virtual event on key Evrysdi data presented at the..	PU
05/25	ROCHE : European Commission approves Venclyxto-based combinations for adults wit..	AQ
05/21	ONCOLYTICS BIOTECH : Announces Clinical and Biomarker Data Demonstrating Clinica..	AQ
05/20	ROCHE : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain ..	AQ
05/20	ROCHE : Pivotal Phase III data at ASCO show Roche's Tecentriq helps certain peop..	AQ
05/19	ROCHE : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain ..	BU
05/18	ROCHE : Diagnostics Canada partners with Canadian Blood Services to include Elec..	AQ
05/11	PROTHENA : Announces achievement of $60 million milestone from roche for first p..	AQ
05/11	ROCHE : to present data from one of the most comprehensive oncology portfolios a..	AQ
05/11	GENENTECH : to Present Data From One of the Most Comprehensive Oncology Portfoli..	BU
05/10	CHUGAI PHARMACEUTICAL : Discontinues Marketing of Photodynamic Diagnostic Agent ..	AQ
05/05	ROCHE : Tecentriq approved by European Commission as a first-line monotherapy tr..	AQ
04/30	ROCHE : Invitation to Roche's virtual event on key oncology data presented at AS..	PU
04/28	ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..	BU
04/28	ROCHE : US FDA Advisory Committee votes in favour of maintaining accelerated app..	AQ
04/28	ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..	AQ
04/28	ROCHE : launches new ways to use their cardiovascular tests empowering clinician..	AQ
04/27	ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..	BU
04/27	ROCHE : US FDA Advisory Committee votes in favour of maintaining accelerated app..	AQ
04/26	ABBVIE : Receives Positive CHMP Opinion for VENCLYXTO (venetoclax) as a Combinat..	AQ

1 2 3 4 5 6 7 8 9 10 Next

Analysis

Roche : to cut 300-400 product development jobs - Blick